A top ten pharmaceutical company partnered with Cerilliant for the development and manufacture of private labeled Snap-N-Shoot^® solution based standards for their proprietary compounds. These proprietary solution standards are distributed to both their internal and external customers.

This innovative research-based pharmaceutical company sees significant benefits of conversion to Snap-N-Shoot^® standards for use in pharmaceutical assays including the elimination of weighing and dilution errors; time spent investigating OOT or OOS results; efficiency of analytical resources; consistency of assay results across locations; material savings; elimination of safety risks related to handling of highly hazardous neat materials in the analytical lab; and convenience of use.

The development process has included solvent studies, production of pilot and commercial batches, development of custom packaging; stability studies, and method transfer activities. Certification is performed using client methods. For compounds still in development, this customer is developing analytical methods and planning regulatory filings that specify the use of solution standards.

Cerilliant was chosen because of our expertise and history in the successful development of solution based standards for a wide range of compounds; our devotion to quality, consistency, robust documentation, and regulatory compliance; our full range of capabilities from organic synthesis to inventory management; and our long-term relationship approach.